Meeting
2016 Gastrointestinal Cancers Symposium
Possible role of the systemic inflammatory reaction in defining tumor responder vs. nonresponder in cancer macrobead therapy.
Authors
Barry H. Smith
The Rogosin Institute, New York, NY
Barry H. Smith , Zoe Padua Andrada , Angelica Nazarian , Allyson J. Ocean , Tapan Parikh , Jia Lu , Anna Arreglado , Thomas J. Fahey III, Nathaniel Berman , Larry Gazda , Prithy Martis , Melissa Laramore , Eugene Akahoho , Joanne Thomas , David J. Wolf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Clinical Trial Registration Number
NCT01053013
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 572)
DOI
10.1200/jco.2016.34.4_suppl.572
Abstract #
572
Poster Bd #
D21
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Prognostic value of serum interleukin-6 and YKL-40 and systemic inflammatory response in patients with unresectable pancreatic cancer.
First Author: Inna Chen
Poster
2015 Gastrointestinal Cancers Symposium
Interleukin-6 (IL-6) as an inflammatory biomarker in patients with hepatobiliary cancers.
First Author: Sidra Anwar
Poster
2015 Gastrointestinal Cancers Symposium
Pre- and postoperative inflammatory response to predict survival in patients undergoing potentially curative resection for colorectal cancer.
First Author: David G. Watt
Poster
2012 ASCO Annual Meeting
Serum hepatocyte growth factor and interleukin-6 as prognostic markers for stage III non-small cell lung cancer.
First Author: Hideki Ujiie